Steven L. Hoerter
2014 - Clovis Oncology
In 2014, Steven L. Hoerter earned a total compensation of $3.5M as EVP and Chief Commercial Officer at Clovis Oncology, a 162% increase compared to previous year.
Compensation breakdown
| Bonus | $136,000 |
|---|---|
| Option Awards | $2,992,022 |
| Salary | $337,417 |
| Other | $13,265 |
| Total | $3,478,704 |
Hoerter received $3M in option awards, accounting for 86% of the total pay in 2014.
Hoerter also received $136K in bonus, $337.4K in salary and $13.3K in other compensation.
Rankings
In 2014, Steven L. Hoerter's compensation ranked 2,525th out of 13,032 executives tracked by ExecPay. In other words, Hoerter earned more than 80.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,525 out of 13,032 | 81st |
Division Manufacturing | 898 out of 4,967 | 82nd |
Major group Chemicals And Allied Products | 276 out of 1,690 | 84th |
Industry group Drugs | 214 out of 1,369 | 84th |
Industry Pharmaceutical Preparations | 176 out of 1,042 | 83rd |
Source: SEC filing on April 27, 2016.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steven L. Hoerter at Clovis Oncology in 2014.